Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Positioning biologic agents in the treatment of Crohn's disease
Stephen B. Hanauer
Medicine, Gastroenterology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Positioning biologic agents in the treatment of Crohn's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Biological Product
100%
Crohn's Disease
100%
Therapeutic Procedure
100%
Patient
75%
Diseases
50%
Combination Therapy
50%
Biological Therapy
50%
Complication
25%
Surgery
25%
Corticosteroid
25%
Tumor Necrosis Factor
25%
Integrin
25%
Immunosuppressive Drug
25%
Maintenance Therapy
25%
Mechanism of Action
25%
Prognosis
25%
INIS
diseases
100%
positioning
100%
therapy
83%
patients
50%
interventions
50%
surgery
16%
risks
16%
maintenance
16%
refractories
16%
algorithms
16%
increasing
16%
tumor necrosis factor
16%
corticosteroids
16%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factors
100%
Corticosteroid
100%